Literature DB >> 16197808

Do pathogen exposure and innate immunity cause brain diseases?

Alain R Simard1, Serge Rivest.   

Abstract

It had long been thought that the central nervous system was isolated from the immune system owing to the blood-brain barrier and that this organ was unable to mount an immune reaction of its own when challenged by invading pathogens. It is now clear that the immune system has a profound impact on the central nervous system, because immune molecules found in the blood stream are able to stimulate cells within the brain. Moreover, recent studies have demonstrated that cells within the central nervous system have the capacity to produce molecules of the innate immune system and that this organ is able to generate a proper immune reaction. This topic has been extensively studied in recent years, and it is becoming clear that the innate immune system is an important modulator of the fate of neurons. Indeed, the precise role(s) of the innate immune response in neurodegenerative diseases is currently under intensive debate. In this review paper, we present evidence either supporting or opposing a role for the innate immune response in these events. The mechanisms by which pathogens interact with the brain and whether such an interaction leads to neurodegenerative disorders are also discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16197808     DOI: 10.1179/016164105X49526

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  15 in total

1.  Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsieh Chu; Nian-Sheng Tzeng; I-Hui Lee; Po-See Chen; Tzung Lieh Yeh; San-Yuan Huang; Yen-Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-23       Impact factor: 4.147

2.  Vitamin d deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells.

Authors:  Marija Djukic; Marie Luise Onken; Sandra Schütze; Sandra Redlich; Alexander Götz; Uwe-Karsten Hanisch; Thomas Bertsch; Sandra Ribes; Andrea Hanenberg; Simon Schneider; Cornelius Bollheimer; Cornel Sieber; Roland Nau
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 3.  Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.

Authors:  Li Qian; Patrick M Flood; Jau-Shyong Hong
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

4.  Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats.

Authors:  Shiou-Lan Chen; Pao-Luh Tao; Chun-Hsien Chu; Shih-Heng Chen; Hsiang-En Wu; Leon F Tseng; Jau-Shyong Hong; Ru-Band Lu
Journal:  J Neuroimmune Pharmacol       Date:  2011-12-29       Impact factor: 4.147

5.  Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment.

Authors:  Shiou-Lan Chen; Sheng-Yu Lee; Pao-Luh Tao; Yun-Hsuan Chang; Shih-Heng Chen; Chun-Hsien Chu; Po See Chen; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  J Neuroimmune Pharmacol       Date:  2012-09-19       Impact factor: 4.147

6.  Toll-like receptor prestimulation increases phagocytosis of Escherichia coli DH5alpha and Escherichia coli K1 strains by murine microglial cells.

Authors:  Sandra Ribes; Sandra Ebert; Dirk Czesnik; Tommy Regen; Andre Zeug; Stephanie Bukowski; Alexander Mildner; Helmut Eiffert; Uwe-Karsten Hanisch; Sven Hammerschmidt; Roland Nau
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

Review 7.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

8.  In vivo and in vitro effects of pilocarpine: relevance to ictogenesis.

Authors:  Nicola Marchi; Emily Oby; Ayush Batra; Laura Uva; Marco De Curtis; Nadia Hernandez; Anette Van Boxel-Dezaire; Imad Najm; Damir Janigro
Journal:  Epilepsia       Date:  2007-07-20       Impact factor: 5.864

9.  Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability.

Authors:  L Uva; L Librizzi; N Marchi; F Noe; R Bongiovanni; A Vezzani; D Janigro; M de Curtis
Journal:  Neuroscience       Date:  2007-11-12       Impact factor: 3.590

10.  Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.

Authors:  Patrick M Flood; Li Qian; Lynda J Peterson; Feng Zhang; Jing-Shan Shi; Hui-Ming Gao; Jau-Shyong Hong
Journal:  Parkinsons Dis       Date:  2011-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.